Advik Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2025 ,inter alia, to consider and approve Notice is hereby given that ....
Awaiting price reaction for this filing.
MPS Pharmaa Limited (formerly known as Advik Laboratories Limited) has informed BSE about a Board meeting scheduled for September 2, 2025 at 4:30 PM at its corporate office in New Delhi. The meeting will mainly deal with AGM-related items for FY 2024-25, including approving the AGM notice, Director's Report, Management Discussion and Analysis, and Corporate Governance Report. The Board will also finalise the date, time, and venue of the AGM, appoint a scrutinizer, and fix the book closure and e-voting dates. Additionally, the Board will consider appointing a Secretarial Auditor for a five-year term from FY 2025-26 to FY 2029-30. The filing also reveals that the company has recently changed its name from Advik Laboratories Limited to MPS Pharmaa Limited.
This is a routine compliance filing ahead of the company's annual general meeting, with no financial results or dividend announcement. Shareholders should watch for the AGM date, book closure period, and e-voting window that will be finalised at this meeting, as they will determine eligibility for voting and any corporate actions tied to the AGM.